x

RSS Newsfeeds

See all RSS Newsfeeds

Jul 31, 2017 3:05 PM ET

Global Fatty Liver Disease Drugs Market By Type, Stages of ALD and NAFLD, Region & Country: Opportunities and Forecast (2017-2022)

iCrowdNewswire - Jul 31, 2017

The “Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) “ report has been added to Research and Markets’ offering.

The global market is projected to display a robust growth represented by a CAGR of 22.67% during 2017-2022, chiefly driven by rising prevalence of obesity, diabetes and hypertension, rising clinical trials in Asian countries, heavy investments by government of different countries in their health care sector, rising research in developing the different health care machines and methodology for the detection of alcohol and non-alcohol steatosis at its early stage.

Over the recent years, the global fatty liver disease incidence has been growing rapidly with increase in prevalence of obesity, type II diabetes along with rising consumption of alcohol. Globally, the growth in the fatty liver disease market is driven by rising awareness among people by government organizations and private companies, heavy investments by pharmaceutical companies for the development of drugs along with launch of drugs for NASH in the forecasted period.

Companies Mentioned

– Allergan
– Astra Zenca
– Conatus
– Gilead Sciences
– Immuron
– Intercept Pharmaceuticals
– Novartis
– Pfizer
– Takeda

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation

4. Fatty Liver Market Outlook

5. Global Fatty Liver Disease Market: Growth and Forecast

6. Global Fatty Liver Disease – Analysis By Type

7. Global Alcoholic Fatty Liver Disease Market – Analysis By Stages

8. Global Non Alcoholic Fatty Liver Disease Market- Analysis By Stages

9. Global Alcoholic Fatty Liver Disease Market – Analysis By Drugs

10. Global Non Alcoholic Fatty Liver Disease Market -By Drugs

11. Global Fatty Liver Disease Market – Pipeline Analysis (By developer, Phase and indication)

12. Global Fatty Liver Disease Market – Regional Analysis

13. North America Fatty liver Disease Market- An Analysis

14. North America Fatty Liver Disease Market -By Country Analysis

15. Asia Pacific Fatty liver Disease Market – An Analysis

16. Asia Pacific Fatty Liver Disease Market – By Country Analysis

17. Europe Pacific Fatty liver Disease Market- An Analysis

18. Europe Fatty Liver Disease Market – By Country Analysis

19. Rest of World Fatty liver Disease Market- An Analysis

20. Rest of World Fatty Liver Disease Market – By Country Analysis

21. Market Dynamics

22. Market Trends

23. Policy and Regulations

24. Porter Five Force

25. SWOT Analysis

26. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/bgh6gr/global_fatty

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs (https://www.researchandmarkets.com/categories.asp?cat_id=753&campaign_id=bgh6gr)

Via iCrowdNewswire
View Related News >